JPH0833395B2 - Method for producing molded article for solid-phase immunoassay - Google Patents
Method for producing molded article for solid-phase immunoassayInfo
- Publication number
- JPH0833395B2 JPH0833395B2 JP61085131A JP8513186A JPH0833395B2 JP H0833395 B2 JPH0833395 B2 JP H0833395B2 JP 61085131 A JP61085131 A JP 61085131A JP 8513186 A JP8513186 A JP 8513186A JP H0833395 B2 JPH0833395 B2 JP H0833395B2
- Authority
- JP
- Japan
- Prior art keywords
- molded article
- solid
- immunoassay
- treatment
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003018 immunoassay Methods 0.000 title claims description 19
- 239000007790 solid phase Substances 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 238000011282 treatment Methods 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 10
- 238000007254 oxidation reaction Methods 0.000 claims description 10
- -1 polypropylene Polymers 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 238000000026 X-ray photoelectron spectrum Methods 0.000 claims description 4
- 239000000427 antigen Substances 0.000 description 13
- 102000036639 antigens Human genes 0.000 description 13
- 108091007433 antigens Proteins 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000001179 sorption measurement Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 6
- 238000009832 plasma treatment Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008105 immune reaction Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229920001342 Bakelite® Polymers 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- CPOBTYJRKAJERX-UHFFFAOYSA-N 3-ethyl-n-[(3-ethyl-1,3-benzothiazol-2-ylidene)amino]-1,3-benzothiazol-2-imine Chemical compound S1C2=CC=CC=C2N(CC)C1=NN=C1SC2=CC=CC=C2N1CC CPOBTYJRKAJERX-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Treatments Of Macromolecular Shaped Articles (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、免疫検査の一手法である固相免疫測定法に
用いられる、試料の容器もしくは、担体等の成形品を製
造する方法に関する。TECHNICAL FIELD The present invention relates to a method for producing a molded article such as a container for a sample or a carrier, which is used in a solid-phase immunoassay method which is one method of immunoassay.
近年、医学の幅広い分野で免疫反応を利用した分析手
法が取り入れられ、血中薬物の定量、癌性たん白質の検
出、組織適合性の決定などが行なわれ、非常に有用な臨
床データを与えている。また、現在著るしい展開を見せ
ているバイオテクノロジーの各分野でも、この免疫反応
を利用した分析手法が取り入れられている。たとえば、
遺伝子変換によって生みだされる生理活性物質の検知や
農作物に感染したウイルスの同定など、この手法は欠く
べからざるものとなっている。In recent years, analytical methods using immune reactions have been adopted in a wide range of fields in medicine, and quantification of drugs in blood, detection of cancerous proteins, determination of histocompatibility, etc. have been carried out, giving extremely useful clinical data. There is. In addition, in each field of biotechnology, which is currently showing remarkable development, the analytical method using this immune reaction is also adopted. For example,
This method is indispensable, such as detection of physiologically active substances produced by gene conversion and identification of viruses that infect crops.
免疫反応を利用した分析法としては種々の方法があ
る。すなわち、免疫拡散法、免疫クロマトグラフィー、
免疫電気泳動法、補体結合反応、赤血球凝集反応、受身
赤血球凝集反応、けい光抗体法、ラジオイムノアッセ
イ、酵素免疫測定法等である。このなかでも、抗原もし
くは抗体を固相上に固定して測定を行う手法を固相免疫
測定法と言い、たとえば固相ラジオイムノアッセイや、
固相酵素免疫測定法(Enzyme Linked Immunosorbent As
say、以下ELISAという)がある。この固相免疫測定法
は、多くの免疫測定法の中でも最も感度高く定量できる
手法である。この測定法は、あらかじめ固相上に抗原も
しくは抗体を固定し、ラジオアイソトープ、けい光性物
質もしくは酵素等の標識物を結合させた抗体もしくは抗
原と、抗原−抗体反応を行わせる。反応物と未反応物の
分離は洗浄によって容易に行う事ができ、固相表面に抗
原−抗体反応によって固定された抗原もしくは抗体は、
標識物を測定する事により定量できる。There are various analytical methods utilizing the immune reaction. That is, immunodiffusion, immunochromatography,
Immunoelectrophoresis, complement fixation reaction, hemagglutination reaction, passive hemagglutination reaction, fluorescent antibody method, radioimmunoassay, enzyme immunoassay and the like. Among these, a method of immobilizing an antigen or antibody on a solid phase for measurement is called a solid phase immunoassay, and for example, a solid phase radioimmunoassay or
Enzyme Linked Immunosorbent As
say, hereinafter referred to as ELISA). This solid-phase immunoassay is the most sensitive quantification method among many immunoassays. In this measuring method, an antigen or antibody is immobilized on a solid phase in advance, and an antigen-antibody reaction is performed with the antibody or antigen to which a labeling substance such as a radioisotope, a fluorescent substance or an enzyme is bound. The reaction product and unreacted product can be easily separated by washing, and the antigen or antibody immobilized on the solid phase surface by the antigen-antibody reaction is
It can be quantified by measuring the labeled substance.
この測定法では、抗原もしくは抗体を固相へ多量に、
且つ安定性良く吸着固定する事が重要であるが、従来、
固相担体の表面に固定される抗原や抗体の量は少なく満
足のいくものではなかった。In this assay, a large amount of antigen or antibody is added to the solid phase,
In addition, it is important to secure and fix with good stability.
The amount of antigens and antibodies immobilized on the surface of the solid phase carrier was small and not satisfactory.
そこで、固相表面に何らかの処理を加えることによっ
て、抗原や抗体が吸着、固定され易くするための研究が
行なわれ、例えば、ポリスチレン系ポリマーの測定用担
体を発煙硫酸または無水硫酸中で処理することによって
スルフォン酸基を導入し、抗原や抗体の固定量を増大さ
せた免疫測定用固相担体(特開昭59-84161号公報)、基
体表面をプラズマ処理することによって基体の表面化学
性を変性し、大分子の結合および/または配向を制御
し、抗体等の結合量を増大させる方法(特開昭59-80442
号公報)等が開示されている。Therefore, studies have been conducted to make it easier for the antigens and antibodies to be adsorbed and fixed by applying some treatment to the solid-phase surface. For example, treating the polystyrene polymer measurement carrier in fuming sulfuric acid or sulfuric anhydride. Sulfonic acid groups were introduced by the method to increase the amount of immobilized antigens and antibodies, and a solid phase carrier for immunoassay (JP-A-59-84161) was used to modify the surface chemistry of the substrate by plasma-treating the substrate surface. And controlling the binding and / or orientation of large molecules to increase the binding amount of antibodies and the like (JP-A-59-80442).
Gazette) is disclosed.
しかしながら、これらの処理によってもなお固体表面
における抗原や抗体の吸着、固定量は十分なものとは言
えず、また、処理方法や条件によっても効果が異なるた
め、吸着、固定量をさらに向上させ、安定化させること
が求められている。However, even with these treatments, the amount of the antigen or antibody adsorbed and immobilized on the solid surface cannot be said to be sufficient, and since the effect varies depending on the treatment method and conditions, the amount of adsorption and immobilization is further improved. Stabilization is required.
本発明は、従来の固相免疫測定法用成形品の持つ欠
点、すなわち抗原の吸着性が十分ではないという点を解
決するため、単なる材質の検討や化学的表面処理の手法
検討にとどまらず、物理的、電気的な検討を鋭意進めた
結果、本発明を完成するに至ったものである。その目的
とするところは、従来は吸着性が低く測定が行えなかっ
た抗原もしくは抗体(たん白質、糖たん白、ペプチド
等)の、吸着安定性を増大することができる免疫測定用
成形品の製造方法を提供するところにある。The present invention solves the drawbacks of conventional molded articles for solid-phase immunoassay, that is, that the adsorptivity of the antigen is not sufficient, and is not limited to merely examining the material and the method of chemical surface treatment. As a result of earnestly proceeding with physical and electrical studies, the present invention has been completed. The purpose is to manufacture molded articles for immunoassays that can increase the adsorption stability of antigens or antibodies (proteins, glycoproteins, peptides, etc.), which had previously been poorly adsorbed and could not be measured. It is in the process of providing a method.
上記の目的を達成するための本発明による固相免疫測
定用成形品は、ポリスチレン成形品もしくはポリプロピ
レン成形品の表面を、X線光電子スペクトルから求めた
酸素原子/炭素原子の比が0.07〜0.19の範囲になるよう
に酸化処理することを構成上の特徴とする。The molded article for solid phase immunoassay according to the present invention for achieving the above object has a surface of a polystyrene molded article or a polypropylene molded article having an oxygen atom / carbon atom ratio of 0.07 to 0.19 determined from X-ray photoelectron spectrum. The structural feature is that the oxidation treatment is performed so as to be within the range.
本発明の固相免疫測定用成形品を構成するプラスチッ
クとしては、ポリスチレンまたはポリプロピレンが選択
使用される。また、成形品の形状は、免疫測定の方法に
よって自ずと決まって来るもので特に限定されるもので
はなく、試験管、ビーズ、マイクロプレート、キュベッ
ト、ディスクなどがその好例である。As the plastic constituting the molded article for solid phase immunoassay of the present invention, polystyrene or polypropylene is selectively used. The shape of the molded product is naturally determined by the immunoassay method and is not particularly limited. Test tubes, beads, microplates, cuvettes, disks and the like are good examples.
このようなプラスチック成形品表面の酸素原子/炭素
原子の比率が0.07〜0.19の範囲になるように調製する手
法としては、酸、アルカリ、過酸化物等の薬品による化
学的処理、コロナ放電処理、低温プラズマ処理、電子線
やガンマー線等の照射などがあるが、特に限定されるも
のではない。The oxygen atom / carbon atom ratio on the surface of such a plastic molded article is adjusted to be in the range of 0.07 to 0.19 by chemical treatment with a chemical such as acid, alkali or peroxide, corona discharge treatment, There are low-temperature plasma treatments, irradiation with electron beams and gamma rays, etc., but they are not particularly limited.
蛋白質のガラス、プラスチック等への吸着現象につい
ては、蛋白質の分離・精製に用いるクロマトグラフィー
の分野で種々の検討が行なわれているが、その吸着に寄
与する力は、疎水結合、イオン結合および水素結合が主
要な作用力であると考えられている。従来の固相免疫測
定用成形品は、主に疎水結合性や化学的に固定する共有
結合性を利用して蛋白質を吸着させるものであった。し
かし、吸着させる蛋白質は、アミノ基、カルボキシル
基、水酸基、カルボニル基などを分子内に数多く有する
高分子であり、疎水結合力のみの場合よりもイオン結合
や水素結合の作用力をも加える方が、吸着固定能が増す
事は明らかである。Regarding the adsorption phenomenon of proteins on glass, plastic, etc., various studies have been conducted in the field of chromatography used for the separation and purification of proteins, but the forces that contribute to the adsorption are hydrophobic bonds, ionic bonds and hydrogen. Bonding is believed to be the main force of action. The conventional molded articles for solid-phase immunoassays mainly adsorb proteins by utilizing hydrophobic bondability or covalent bond property for chemically fixing. However, the protein to be adsorbed is a polymer having a large number of amino groups, carboxyl groups, hydroxyl groups, carbonyl groups, etc. in the molecule, and it is better to add ionic bond or hydrogen bond action force than the case where only hydrophobic bond force is applied. It is clear that the adsorptive fixing ability is increased.
本発明は、ポリスチレンもしくはポリプロピレンから
なる成形品の表面に酸化処理を施し、疎水結合性に加え
てイオン結合力、水素結合力をも吸着に寄与させようと
するもので、特に、炭化処理の方法に応じて処理条件を
選択し、成形品表面のX線光電子スペクトルから求めた
酸素原子/炭素原子の比率が0.07〜0.19の範囲になるよ
うに酸化度合を調節することによって、蛋白質の吸着固
定能を著るしく増大させるものである。酸素原子/炭素
原子の比率が0.07未満では、イオン結合力や水素結合力
が吸着に十分寄与せず、また、0.19以上、即ち過度に酸
化処理を行なった場合には、酸化度合が強くなりすぎる
ために蛋白質の疎水結合性が抑制され、特殊な蛋白質、
たとえば塩基性の蛋白質の吸着性は大きくなるが、一般
的には吸着性は低下する。The present invention is to oxidize the surface of a molded article made of polystyrene or polypropylene to try to contribute to the adsorption of not only hydrophobic bond but also ionic bond force and hydrogen bond force. Depending on the treatment conditions, the adsorption degree of protein can be fixed by adjusting the degree of oxidation so that the oxygen atom / carbon atom ratio obtained from the X-ray photoelectron spectrum of the surface of the molded article is in the range of 0.07 to 0.19. Is a significant increase. When the oxygen atom / carbon atom ratio is less than 0.07, the ionic bond force and the hydrogen bond force do not sufficiently contribute to the adsorption, and when it is 0.19 or more, that is, when the oxidation treatment is excessively performed, the oxidation degree becomes too strong. Therefore, the hydrophobic binding property of the protein is suppressed, and a special protein,
For example, the adsorptivity of basic proteins increases, but the adsorptivity generally decreases.
免疫測定の対象となる蛋白質の種類は多様であり、従
って、免疫測定用成形品表面の酸化状態もこれに対応し
て各種のものを用意するのが望ましいが、本発明によれ
ば、酸化処理の方法と処理条件を組合せて、酸素原子/
炭素原子の比率を調節することにより、使用目的に応じ
た一定の蛋白質吸着性を有する免疫測定用成形品を調製
することができる。There are various kinds of proteins to be subjected to the immunoassay, and therefore it is desirable to prepare various types of oxidation states on the surface of the molded article for immunoassay, according to the present invention. Of the oxygen atoms /
By adjusting the ratio of carbon atoms, it is possible to prepare an immunoassay molded article having a certain protein adsorption property according to the purpose of use.
尚、酸、アルカリ等の薬品による化学的処理は、プラ
スチックの材質により試薬の選択が必要であり、また、
処理後は反応液を十分洗浄しおく事が必要である。この
処理法は、物理的処理であるドライ法に比して、表面原
子の酸化の他に表面をミクロなレベルで粗面化する効果
もあり、吸着性をより増大させる特徴を有する。一方、
物理的処理であるコロナ放電、低温プラズマ処理、電子
線照射、ガンマ線照射などは、表面の原子のみの酸化が
可能で、均一な表面状態を形成する事ができる。In addition, chemical treatment with chemicals such as acids and alkalis requires selection of reagents depending on the plastic material.
After the treatment, it is necessary to wash the reaction solution sufficiently. Compared with the dry method which is a physical treatment, this treatment method has an effect of roughening the surface at a microscopic level in addition to the oxidation of surface atoms, and has a characteristic of further increasing the adsorptivity. on the other hand,
Physical treatments such as corona discharge, low temperature plasma treatment, electron beam irradiation, and gamma ray irradiation can oxidize only the surface atoms and form a uniform surface state.
本発明により得られた固相免疫測定用成形品は、抗原
もしくは抗体の吸着固定性にすぐれ、良好な免疫学的分
析結果を与えるもので、医療診断分野、バイオテクノロ
ジーの研究分野等で極めて有用なものである。また、成
形品の形状を問わずいかなる形状へも応用が可能であ
る。The molded article for solid-phase immunoassay obtained by the present invention is excellent in adsorption immobilization of antigen or antibody and gives good immunological analysis results, and is extremely useful in the fields of medical diagnostics, research fields of biotechnology, etc. It is something. Further, it can be applied to any shape regardless of the shape of the molded product.
以下、実施例により本発明を説明する。 Hereinafter, the present invention will be described with reference to examples.
実施例1 ポリスチレン製の96ウエルマルチプレート(住友ベー
クライト(株)製)を用意し、何らの処理も施さないも
の、ガンマ線を3.0、6.0、8.0および15.0Mrad照射した
もの、低温プラズマ処理(空気圧0.2Torr、周波数13.56
MHz、出力50W)を5および10分間行なったもの、および
7分間低温プラズマ処理した後、さらに5%過酸化水素
溶液中に40℃、60分間浸漬処理したものを調整し、それ
ぞれ試料(1)〜試料(8)とした。また、比較試料と
してFlow社製の組織培養用プレートを用いた。Example 1 A polystyrene 96-well multiplate (manufactured by Sumitomo Bakelite Co., Ltd.) was prepared and subjected to no treatment, gamma ray irradiation of 3.0, 6.0, 8.0 and 15.0 Mrad, low temperature plasma treatment (air pressure 0.2). Torr, frequency 13.56
(5 MHz, output 50 W) for 5 and 10 minutes, and low temperature plasma treatment for 7 minutes, and then dipping treatment in 5% hydrogen peroxide solution at 40 ° C for 60 minutes. ~ Sample (8). A tissue culture plate manufactured by Flow Co. was used as a comparative sample.
これらの各試料について、アルバックファイ社製のX
線光電子分析装置により測定したX線光電子スペクトル
から、試料表面の酸素原子/炭素原子の比率を求めた。For each of these samples, X made by ULVAC-PHI
The oxygen atom / carbon atom ratio on the sample surface was determined from the X-ray photoelectron spectrum measured by a line photoelectron analyzer.
一方、抗体(蛋白質)に対する吸着性評価は以下のと
おり行なった。まず、プレートの各ウエルに、アルカリ
フォスファターゼ標識イムノグロブリンG(抗体)(Mi
les社製)を1000倍および10000倍にそれぞれ希釈したリ
ン酸塩緩衝液を100μl/ウエルづつ加え、37℃で60分間
吸着させた後、ツィーン20(東京化成社製)0.05%含有
生理食塩水(以下、洗浄液と言う)で3回洗浄して、プ
レートへの未吸着分を除去した。次に、基質液(フェニ
ルリン酸2−ナトリウム3.8mM、4−アミノアンチピリ
ン5.4mM、および塩化マグネシウム50nMを含む0.05M炭酸
塩緩衝液)を100μl/ウエル加え、37℃で60分酵素反応
を行った。フェリシアン化カリウムの36mM溶液100μl/
ウエルを加えて反応を停止した後、波長492nmの光で反
応液の吸光度を測定した。On the other hand, the evaluation of the adsorptivity to the antibody (protein) was performed as follows. First, in each well of the plate, the alkaline phosphatase labeled immunoglobulin G (antibody) (Mi
100 μl / well of phosphate buffer diluted 1000 times and 10000 times respectively, and adsorbed at 37 ° C. for 60 minutes, and then Tween 20 (Tokyo Kasei) 0.05% physiological saline solution (Hereinafter, it is called a washing solution), and washed three times to remove unadsorbed components on the plate. Next, a substrate solution (0.05-M carbonate buffer solution containing 2-sodium phenylphosphate 3.8 mM, 4-aminoantipyrine 5.4 mM, and magnesium chloride 50 nM) was added at 100 µl / well, and the enzyme reaction was performed at 37 ° C for 60 minutes. It was 100 μl / 36 mM potassium ferricyanide solution
After adding a well to stop the reaction, the absorbance of the reaction solution was measured with light having a wavelength of 492 nm.
測定結果は第1表に示した通りで、酸素原子/炭素原
子の比率を0.0714〜0.1357調節して酸化処理することに
より、吸光度、即ち抗体に対する吸着性が増大するが、
酸素原子/炭素原子の比率が0.318では酸化が不足して
吸光度が十分に増大せず、他方、比率が0.231になると
酸化が進み過ぎて吸着性が低くなることが分かる。な
お、比較に用いたFlow社製のプレートは酸素原子/炭素
原子比が0.32と大きいため、吸光度は極端に減退してい
ることが認められる。The measurement results are as shown in Table 1, and by adjusting the oxygen atom / carbon atom ratio to 0.0714 to 0.1357 and performing the oxidation treatment, the absorbance, that is, the adsorptivity to the antibody increases,
It can be seen that when the oxygen atom / carbon atom ratio is 0.318, the oxidation is insufficient and the absorbance does not increase sufficiently, while when the ratio is 0.231, the oxidation proceeds too much and the adsorptivity decreases. In addition, since the plate made by Flow Co. used for comparison has a large oxygen atom / carbon atom ratio of 0.32, it is recognized that the absorbance is extremely decreased.
実施例2 住友ベークライト(株)製5mlポリプロピレンチュー
ブに、アルゴンガス中で20秒間低温プラズマ処理を行っ
た(圧力0.2Torr、周波数13.56MHz、出力50W)。表面の
酸素原子/炭素原子比の測定は、実施例1と同様にして
行った。 Example 2 A 5 ml polypropylene tube manufactured by Sumitomo Bakelite Co., Ltd. was subjected to low temperature plasma treatment in argon gas for 20 seconds (pressure 0.2 Torr, frequency 13.56 MHz, output 50 W). The oxygen atom / carbon atom ratio on the surface was measured in the same manner as in Example 1.
ヒト・アルブミンを生理食塩水により夫々1、10、10
0μg/mlの濃度に調製した溶液を、チューブに500μl加
え37℃、60分間吸着させた。洗浄液で3回洗い、ブロッ
キング操作として1%ゼラチン溶液を600μl加え37℃
で60分反応した。洗浄液で3回洗浄した後、抗ヒト・ア
ルブミン抗体(ペルオキシダーゼ標識、カペル社製)を
500μl加えて、抗原であるヒト・アルブミンと反応さ
せた。未反応分を洗浄除去した後、基質液(2,2′−ア
ジノジ(3−エチルベンズチアゾリン)−6′−スルホ
ン酸2アンモニウム塩2.5mM、過酸化水素水5mM)を500
μl加えて37℃で20分反応させた。0.05%窒化ナトリウ
ム100μlにより反応を停止した後、フローセル型分光
光度計で405nmの波長で吸光度を測定した。Human albumin in physiological saline was 1, 10, 10 respectively.
A solution adjusted to a concentration of 0 μg / ml was added to the tube in an amount of 500 μl and allowed to adsorb at 37 ° C. for 60 minutes. Wash 3 times with washing solution and add 600 μl of 1% gelatin solution as blocking operation at 37 ℃
And reacted for 60 minutes. After washing three times with a washing solution, anti-human albumin antibody (peroxidase labeled, manufactured by Capel)
500 μl was added and reacted with the antigen, human albumin. After washing and removing the unreacted portion, the substrate solution (2,2′-azinodi (3-ethylbenzthiazoline) -6′-sulfonic acid diammonium salt 2.5 mM, hydrogen peroxide solution 5 mM) was added to 500
μl was added and reacted at 37 ° C. for 20 minutes. After stopping the reaction with 100 μl of 0.05% sodium nitride, the absorbance was measured at a wavelength of 405 nm with a flow cell type spectrophotometer.
測定結果は第2表に示した通りで、プラズマ処理によ
り酸素原子/炭素原子の比率が0.190になるように表面
酸化した成形チューブは未処理チューブに比べて大幅に
吸光度が増大していることが認められる。The measurement results are as shown in Table 2, and the molded tube surface-oxidized so that the ratio of oxygen atoms / carbon atoms by plasma treatment was 0.190 showed a significant increase in absorbance compared to the untreated tube. Is recognized.
Claims (1)
ン成形品の表面を、X線光電子スペクトルから求めた酸
素原子/炭素原子の比が0.07〜0.19の範囲になるように
酸化処理することを特徴とする固相免疫測定用成形品の
製造方法。1. A solid phase characterized by subjecting the surface of a polystyrene molded product or a polypropylene molded product to an oxidation treatment such that the oxygen atom / carbon atom ratio determined from X-ray photoelectron spectra is in the range of 0.07 to 0.19. Manufacturing method of molded article for immunoassay.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61085131A JPH0833395B2 (en) | 1986-04-15 | 1986-04-15 | Method for producing molded article for solid-phase immunoassay |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61085131A JPH0833395B2 (en) | 1986-04-15 | 1986-04-15 | Method for producing molded article for solid-phase immunoassay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62242857A JPS62242857A (en) | 1987-10-23 |
| JPH0833395B2 true JPH0833395B2 (en) | 1996-03-29 |
Family
ID=13850095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61085131A Expired - Fee Related JPH0833395B2 (en) | 1986-04-15 | 1986-04-15 | Method for producing molded article for solid-phase immunoassay |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0833395B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2532651B2 (en) * | 1988-03-30 | 1996-09-11 | ヘキストジャパン株式会社 | Manufacturing method of antinuclear antibody measuring instrument |
| JPH0271152A (en) * | 1988-09-07 | 1990-03-09 | Terumo Corp | Manufacture of molding for solid phase immunity measurement |
| IT1265355B1 (en) * | 1993-11-26 | 1996-11-22 | Biomat Snc | PROCEDURE TO OBTAIN ARTICLES FOR IMMUNOLOGICAL TESTS WITH IMPROVED PROPERTIES |
| DE19948087B4 (en) * | 1999-10-06 | 2008-04-17 | Evotec Ag | Process for the preparation of a reaction substrate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6049263A (en) * | 1983-08-29 | 1985-03-18 | Tokuyama Soda Co Ltd | Reagent for diagnosis |
-
1986
- 1986-04-15 JP JP61085131A patent/JPH0833395B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62242857A (en) | 1987-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5061640A (en) | Process for preparing a carrier useful in immunoassays by deposition of a complex of a specifically binding substance with hydrophobic protein, and the resulting carrier | |
| USRE34312E (en) | Process and reagent for the determination of an antibody | |
| CA1200761A (en) | Devices and kits for immunological analysis | |
| JPS6367661B2 (en) | ||
| JPS60142259A (en) | Immobilized antibody | |
| AU724475B2 (en) | Synthetic particles as agglutination reagents | |
| JP2004516489A (en) | Protein chip, method for producing the same, detection system using the protein chip, and method using the detection system | |
| WO1993016387A1 (en) | Solid-phase reagent and assay of antibody using the same | |
| JPH09159673A (en) | Microplate | |
| JP3584616B2 (en) | Microplate | |
| JPH0439623B2 (en) | ||
| JPH01209370A (en) | Method and apparatus for measuring immunologically active substance | |
| WO2000039582A1 (en) | Container for immunologic assay | |
| CN107255713B (en) | It can be used for diagnosing the kit of human enterovirus infection | |
| JP4432252B2 (en) | Method for producing protein-adsorbing carrier and measuring method using the carrier | |
| JPH11248706A (en) | Non-specific adsorption inhibitor | |
| JPS62242857A (en) | Molding for solid phase immunological measurement | |
| EP0228225A2 (en) | Immunoassay kit and method employing modified solid surface | |
| CN112903997B (en) | EB virus capsid antigen IgA antibody enzyme-linked immunoassay kit and detection method thereof | |
| CN112903998B (en) | EB virus NA1-IgA antibody enzyme-linked immunoassay kit and detection method thereof | |
| US5783455A (en) | Regenerable solid phase for carrying out specific binding reactions | |
| RU2089912C1 (en) | Method of stereospecific analysis and a method of preparing conjugate for stereospecific analysis | |
| Mandenius et al. | [35] Coupling of biomolecules to silicon surfaces for use in ellipsometry and other related techniques | |
| JPS6015560A (en) | Immunological measuring molded article and preparation thereof | |
| JPS58221166A (en) | Carrier for immunochemical measurement and measuring reagent using this carrier |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |